Analytical Data
-
Gene name
CDC42SE2
- Application
-
Alternative Names
CDC42SE2; SPEC2CDC42 small effector Protein 2; Small effector of CDC42 Protein 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NRR3
-
Expression Region
1-84aa
-
AA Sequence
MSEFWLCFNC CIAEQPQPKR RRRIDRSMIG EPTNFVHTAH VGSGDLFSGM NSVSSIQNQM QSKGGYGGGM PANVQMQLVD TKAG
-
Molecular Weight
9.2 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CDC42SE2 (Cdc42 small effector 2) is a member of the CDC42 effector protein family, which is known to play critical roles in various cellular processes, including cell shape, motility, and division. This protein interacts with the small GTPase CDC42, a key regulator of cytoskeletal dynamics. The interest in CDC42SE2 has grown due to its potential involvement in several pathophysiological conditions, including cancer metastasis and neurodegenerative diseases. Research has suggested that CDC42SE2 may influence actin cytoskeleton dynamics and cell signaling pathways, thereby affecting cellular behaviors such as migration and invasion. Understanding the molecular mechanisms of CDC42SE2 function and its interactions with other proteins could provide valuable insights into its role in health and disease. Additionally, the recombinant expression of CDC42SE2 allows for the exploration of its biochemical properties and functional assays, facilitating the development of therapeutic strategies targeting its pathways. As a result, CDC42SE2 stands out as a promising candidate for further investigation in the context of cell biology and disease progression.
